Therapeutic Drug Monitoring (TDM) of Suspension (SUS), Extended-Release (ER), and Intravenous (IV) Posaconazole (POS) at a Large Transplant Center

DOI: 10.1093/ofid/ofx163.683

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text